Medtronic’s MiniMed exchange offer oversubscribed, about 18% of shares to be accepted
Medtronic received tenders for roughly 298 million of its ordinary shares in the exchange offer for MiniMed and will accept about 55 million shares on a pro‑rata basis, delivering roughly 253 million MiniMed shares. The offer was oversubscribed, leading to an estimated acceptance rate of 18.3 %. Goldman Sachs & Co. LLC and BofA Securities, Inc. served as the dealer managers for the transaction.
Why it matters
The limited acceptance means only a fraction of Medtronic shares will be exchanged, reducing the immediate dilution of MiniMed shares while leaving most Medtronic shares outstanding. Investors should note the pro‑rata allocation and the pending proration factor expected on October 14.
Key facts
- 1Equiniti Trust reported that 298,024,452 Medtronic ordinary shares were validly tendered and not withdrawn. stocktitan.net
- 2Medtronic plans to accept 55,032,401 of the tendered shares in exchange for 252,813,348 MiniMed common shares. stocktitan.net
- 3The acceptance rate is estimated at approximately 18.3 % on a pro‑rata basis, excluding odd‑lot shareholders. stocktitan.net
- 4Goldman Sachs & Co. LLC and BofA Securities, Inc. acted as the dealer managers for the exchange offer. stocktitan.net
- 5Following the announcement, Medtronic’s share price rose about 3 % to roughly $91. gurufocus.com
- 6MiniMed shares fell nearly 3 % to $19.13 after the news. gurufocus.com
Summary written by AlphAI AI Desk from 3 of 3 sources. Not investment advice. Figures are as stated by the linked sources.